サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1511923

コンピテントセルの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
コンピテントセルの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年06月20日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コンピテントセル市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のコンピテントセル市場規模は、2024年から2030年にかけて8.10%のCAGRを示し、2030年には35億9,000万米ドルに達すると予測されています。

バイオ医薬品研究の増加、遺伝子編集技術の進歩、合成生物学分野の拡大が市場成長を促進すると見られています。さらに、バイオテクノロジーや製薬産業は、組換えタンパク質、酵素、ワクチンの生産にコンピテントセルに大きく依存しています。治療、研究、産業用途でこれらの製品に対するニーズが高まっていることが、コンピテントセルの需要を促進しています。

COVID-19パンデミックはコンピテントセル市場を大きく押し上げました。コンピテント細胞は、分子クローニング、遺伝子工学、組換えタンパク質の製造などの作業に不可欠であり、ワクチン、診断検査、治療研究の作成に重要な役割を果たすため、需要が高まっています。ワクチンの製造やCOVID-19の治療が急務であることから、バイオテクノロジー企業や製薬企業はクローニングプロセスの改善に取り組んでいます。このような要因が市場の成長を後押ししており、予測期間中に飛躍的な成長が見込まれます。

さらに、細胞調製における技術的進歩がコンピテント細胞の需要をさらに促進すると予測されています。コンピテント細胞の調製と形質転換効率における技術的進歩は、コンピテント細胞の性能と信頼性に大きな影響を与えており、その結果、研究者や産業ユーザーの需要が増加しています。さらに、遺伝子組み換えやストレス応答経路の開発が形質転換の達成度をさらに高め、特定の用途に合わせたソリューションを提供し、様々な分野におけるコンピテントセルの有用性を進めています。このような要因が、予測期間中の市場の成長を促進すると予測されます。

しかし、高効率のコンピテントセルを製造・維持するためのコストは高く、特に予算が限られている小規模の研究機関や新興企業にとっては、その利用が制限される可能性があります。このことは、特定の市場におけるコンピテントセルの採用率に影響を及ぼすと予想されます。さらに、コンピテントセルを調製し、形質転換を成功させるプロセスは技術的に複雑で、専門的な知識や装置を必要とする可能性があります。そのため、予測期間中の市場成長の妨げとなります。

コンピテントセル市場レポートハイライト

  • 化学的コンピテントセルは、組み換えDNA技術や分子生物学の分野で広く使用されているため、2023年には43.62%の最大市場シェアを占めました。一方、エレクトロ・コンピテント細胞は予測期間中に最も速いCAGRで成長すると予測されています。
  • 2023年には、クローニングセグメントがアプリケーションセグメントの市場シェアを独占すると予想されます。しかし、タンパク質発現セグメントは、様々な産業および学術用途で必要とされる組換えタンパク質や酵素の需要増に牽引され、予測期間中CAGR 9.04％で最速成長すると予測されています。
  • 製薬＆バイオテクノロジー企業セグメントは、規制基準を満たすために必要ないくつかの定性的検査とともに、創薬と薬剤開発のためのコンピテント細胞に対する需要の高まりにより、2023年に最大のシェアを占め、最終用途セグメントを支配しました。
  • 北米地域は34.13%のシェアで市場を独占しているが、これはバイオテクノロジー、医療、治療における強力な研究開発、政府からの多額の資金提供などの要因によるものです。アジア太平洋地域は予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 コンピテントセル市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助的な市場見通し。
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • コンピテントセル市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 コンピテントセル市場：タイプ別推定・動向分析

  • セグメントダッシュボード
  • 世界のコンピテントセル市場：タイプ変動分析
  • 世界のコンピテントセル市場規模と動向分析、タイプ別、2018～2030年
  • ケミカルコンピテントセル
  • エレクトロコンピテントセル
  • ウルトラコンピテントセル

第5章 コンピテントセル市場：用途別推定・動向分析

  • セグメントダッシュボード
  • 世界のコンピテントセル市場：用途変動分析
  • 世界のコンピテントセル市場規模と動向分析、用途別、2018～2030年
  • クローン
  • タンパク質発現
  • 突然変異誘発
  • その他

第6章 コンピテントセル市場：最終用途別推定・動向分析

  • セグメントダッシュボード
  • 世界のコンピテントセル市場：最終用途変動分析
  • 世界のコンピテントセル市場規模と動向分析、最終用途別、2018～2030年
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • その他

第7章 コンピテントセル市場：地域別推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
    • 北米市場推計・予測2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 2018年から2030年までの欧州市場推計・予測
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋市場推計・予測2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ市場推計・予測2018年から2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2023年
  • 企業プロファイル/上場企業
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Takara Bio Inc.
    • New England Biolabs（UK）Ltd.
    • Promega Corporation
    • Bio-Rad Laboratories
    • Roche Applied Science
    • Qiagen
    • SGI-DNA（Synthetic Genomics, Inc.）
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global competent cells market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Mexico competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 France competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 30 France competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 31 France competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Sweden competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 China competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 52 China competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 53 China competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Japan competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 58 India competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 59 India competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Australia competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Latin America competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 MEA competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 UAE competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait competent cells market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Competent cells market: Market outlook
  • Fig. 5 Competent cells market: Segment outlook
  • Fig. 6 Competent cells market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Competent cells market driver impact
  • Fig. 9 Competent cells market restraint impact
  • Fig. 10 Competent cells market: Type outlook and key takeaways
  • Fig. 11 Competent cells market: Type movement analysis
  • Fig. 12 Chemically competent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Electrocompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Ultracompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Competent cells market: Application outlook and key takeaways
  • Fig. 16 Competent cells market: Application movement analysis
  • Fig. 17 Cloning market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Mutagenesis market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Competent cells market: End-use outlook and key takeaways
  • Fig. 22 Competent cells market: End-use movement analysis
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global competent cells market: Regional outlook and key takeaways
  • Fig. 27 Global competent cells market: Regional movement analysis
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-310-3

Competent Cells Market Growth & Trends:

The global competent cells market size is anticipated to reach USD 3.59 billion by 2030, exhibiting a CAGR of 8.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing biopharmaceutical research, advancements in gene editing technologies, and the expanding field of synthetic biology is expected to propel market growth. Moreover, the biotechnology and pharmaceutical industries depend heavily on competent cells for the production of recombinant proteins, enzymes, and vaccines. The growing need for these products in medical treatments, research, and industrial applications fuels the demand for competent cells.

The COVID-19 pandemic has significantly boosted the market for competent cells, as companies increased their research and development efforts to address immediate health and scientific challenges. Competent cells, vital for tasks like molecular cloning, genetic engineering, and making recombinant proteins, have been in higher demand due to their key role in creating vaccines, diagnostic tests, and therapeutic research. The urgent need for vaccine manufacturing and treatments for COVID-19 has driven biotech and pharmaceutical companies to improve their cloning processes. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.

In addition, technological advancements in cell preparation are projected to further propel the demand for competent cells. Technological advancements in the preparation and transformation efficiency of competent cells have significantly impacted the performance and reliability of competent cells, thus increasing the demand for researchers and industrial users. Additionally, genetic modifications and stress response pathway developments have further boosted transformation accomplishment, providing tailored solutions for specific applications, and advancing the utility of competent cells in various fields. These factors are thus projected to impel the growth of the market over the forecast period.

However, the high cost of producing and maintaining high-efficiency competent cells is considerable, which may limit their accessibility, especially for smaller research institutions and startups with limited budgets. This is anticipated to affect the adoption rate of competent cells in certain markets. Moreover, the process of preparing competent cells and accomplishing successful transformations could be technically complex and involve specialized knowledge and equipment. Thereby, hampering the growth of the market over the forecast period.

Competent Cells Market Report Highlights:

  • The chemically competent cells segment held the largest market share of 43.62% in 2023 due to their wide use in the field of recombinant DNA technology, and molecular biology. On the other hand, electrocompetent cells are anticipated to grow at the fastest CAGR over the forecast period.
  • In 2023, the cloning segment is anticipated to dominate the market share for the application segment. However, the protein expression segment is expected to grow at the fastest CAGR of 9.04% over the forecast period driven by the increasing demand for recombinant proteins and enzymes required in various industrial and academic applications.
  • The pharmaceutical & biotechnology companies segment dominated the end-use segment with the largest share in 2023 due to the rising demand for competent cells for drug discovery and development, along with the few qualitative tests required to fulfill the regulatory standards.
  • The North America region dominated the market with a share of 34.13% owing to factors such as strong R&D in biotechnology, medicine, and therapeutics, along with substantial government funding. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Competent Cells Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing demand for recombinant proteins and antibodies
      • 3.2.1.2. Growing biotechnology and pharmaceutical industries
      • 3.2.1.3. Increasing research and development activities
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Costs of Competent Cells
  • 3.3. Competent Cells Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Competent Cells Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Competent Cells Market Type Movement Analysis
  • 4.3. Global Competent Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Chemically Competent Cells
    • 4.4.1. Chemically competent cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Electrocompetent Cells
    • 4.5.1. Electrocompetent cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Ultracompetent Cells
    • 4.6.1. Ultracompetent cells market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Competent Cells Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Competent Cells Market Application Movement Analysis
  • 5.3. Global Competent Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cloning
    • 5.4.1. Cloning market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Protein Expression
    • 5.5.1. Protein expression market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Mutagenesis
    • 5.6.1. Mutagenesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competent Cells Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Competent Cells Market End-use Movement Analysis
  • 6.3. Global Competent Cells Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competent Cells Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive scenario
      • 7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Agilent Technologies, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Takara Bio Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. New England Biolabs (UK) Ltd.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Bio-Rad Laboratories
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Roche Applied Science
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Qiagen
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. SGI-DNA (Synthetic Genomics, Inc.)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives